United States · FDA National Drug Code directory
Kineret
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 66658-234_d1acb9d5-9241-4aeb-b3e7-f05dbc8c15a2
- Product NDC
- 66658-234
- Form
- INJECTION, SOLUTION
- Composition / generic term
- anakinra
- Labeler
- Swedish Orphan Biovitrum AB (publ)
- Marketing category
- BLA
- Marketing start / end (source format)
- 20091215
- Source listing expiry
- 20271231
Source-listed ingredients
- ANAKINRA — 100 mg/.67mL
These values do not establish equivalence or a dose recommendation.
Packages
- 7 SYRINGE, GLASS in 1 CARTON (66658-234-07) / .67 mL in 1 SYRINGE, GLASS · 66658-234-07
- 4 CARTON in 1 CASE (66658-234-28) / 7 SYRINGE, GLASS in 1 CARTON / .67 mL in 1 SYRINGE, GLASS · 66658-234-28
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →